<i>C21orf5</i>, a human candidate gene for brain abnormalities and mental retardation in Down syndrome-Reference-Cited by-同舟云学术

C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome

Published:2005-11-03 Issue:1-2 Volume:112 Page:16-22
ISSN:1424-8581
Container-title:Cytogenetic and Genome Research
language:en
Short-container-title:Cytogenet Genome Res

Author:

Rachidi M.,Lopes C.,Delezoide A.-L.,Delabar J.M.

Publisher

S. Karger AG

Subject

Genetics(clinical),Genetics,Molecular Biology

Reference38 articles.

1. Down syndrome-critical region contains a gene homologous to Drosophila sim expressed during rat and human central nervous system development.

2. Transcriptional Map of the 2.5-Mb CBR–ERG Region of Chromosome 21 Involved in Down Syndrome

3. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

4. Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21

5. Epstein CJ: Down syndrome (trisomy 21), in: Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, pp 749-794 (McGraw-Hill, New York 1995).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole exome sequencing identified a homozygous novel variant in DOP1A gene in the Pakistan family with neurodevelopmental disabilities: case report and literature review;Frontiers in Genetics;2024-05-16

2. Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans;Frontiers in Cell and Developmental Biology;2022-05-23

3. Identifying Patients with Atrioventricular Septal Defect in Down Syndrome Populations by Using Self-Normalizing Neural Networks and Feature Selection;Genes;2018-04-12

4. Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals;PLoS ONE;2012-12-05

5. Mental Retardation and Human Chromosome 21 Gene Overdosage: From Functional Genomics and Molecular Mechanisms Towards Prevention and Treatment of the Neuropathogenesis of Down Syndrome;Genomics, Proteomics, and the Nervous System;2010-11-25